Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer

Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) have been demonstrated to deliver therapeutic drugs in preclinical studies. However, their use is limited, as they lack the ability to specifically deliver drugs to tumor tissues in vivo. In the present study, we propose the use of a t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangadaran, Prakash, Gunassekaran, Gowri Rangaswamy, Rajendran, Ramya Lakshmi, Oh, Ji Min, Vadevoo, Sri Murugan Poongkavithai, Lee, Ho Won, Hong, Chae Moon, Lee, Byungheon, Lee, Jaetae, Ahn, Byeong-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406005/
https://www.ncbi.nlm.nih.gov/pubmed/36009525
http://dx.doi.org/10.3390/biomedicines10081978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406005/
https://www.ncbi.nlm.nih.gov/pubmed/36009525
http://dx.doi.org/10.3390/biomedicines10081978

Ejemplares similares